Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
PLoS One. 2013 Dec 4;8(12):e82512. doi: 10.1371/journal.pone.0082512. eCollection 2013.
BACKGROUND/AIMS: The neural cell adhesion molecule L1CAM is a transmembrane glycoprotein abnormally expressed in tumors and previously associated with cell proliferation, adhesion and invasion, as well as neurite outgrowth in endometriosis. Being an attractive target molecule for antibody-based therapy, the present study assessed the ability of the monoclonal anti-L1 antibody (anti-L1 mAb) to impair the development of endometriotic lesions in vivo and endometriosis-associated nerve fiber growth.
Endometriosis was experimentally induced in sexually mature B6C3F1 (n=34) and CD-1 nude (n=21) mice by autologous and heterologous transplantation, respectively, of endometrial fragments into the peritoneal cavity. Transplantation was confirmed four weeks post-surgery by in vivo magnetic resonance imaging and laparotomy, respectively. Mice were then intraperitoneally injected with anti-L1 mAb or an IgG isotype control antibody twice weekly, over a period of four weeks. Upon treatment completion, mice were sacrificed and endometrial implants were excised, measured and fixed. Endometriosis was histologically confirmed and L1CAM was detected by immunohistochemistry. Endometriotic lesion size was significantly reduced in anti-L1-treated B6C3F1 and CD-1 nude mice compared to mice treated with control antibody (P<0.05). Accordingly, a decreased number of PCNA positive epithelial and stromal cells was detected in autologously and heterologously induced endometriotic lesions exposed to anti-L1 mAb treatment. Anti-L1-treated mice also presented a diminished number of intraperitoneal adhesions at implantation sites compared with controls. Furthermore, a double-blind counting of anti-neurofilament L stained nerves revealed significantly reduced nerve density within peritoneal lesions in anti-L1 treated B6C3F1 mice (P=0.0039).
Local anti-L1 mAb treatment suppressed endometriosis growth in B6C3F1 and CD-1 nude mice and exerted a potent anti-neurogenic effect on induced endometriotic lesions in vivo. The findings of this preliminary study in mice provide a strong basis for further testing in in vivo models.
背景/目的:神经细胞黏附分子 L1CAM 是一种跨膜糖蛋白,在肿瘤中异常表达,与细胞增殖、黏附和侵袭以及子宫内膜异位症中的神经突生长有关。作为抗体治疗的有吸引力的靶分子,本研究评估了单克隆抗 L1 抗体(抗 L1 mAb)在体内损害子宫内膜异位症病变发展和与子宫内膜异位症相关的神经纤维生长的能力。
通过将子宫内膜碎片自体和异体移植到腹腔中,分别在性成熟的 B6C3F1(n=34)和 CD-1 裸鼠(n=21)中实验性诱导子宫内膜异位症。手术后四周分别通过体内磁共振成像和剖腹术确认移植。然后,将抗 L1 mAb 或 IgG 同种型对照抗体每周两次腹腔内注射,持续四周。治疗完成后,处死小鼠,切除子宫内膜植入物,测量并固定。通过组织学确认子宫内膜异位症,并通过免疫组织化学检测 L1CAM。与用对照抗体治疗的小鼠相比,用抗 L1 mAb 治疗的 B6C3F1 和 CD-1 裸鼠的子宫内膜异位症病变大小显著减小(P<0.05)。因此,在暴露于抗 L1 mAb 治疗的自体和异体诱导的子宫内膜异位症病变中,检测到 PCNA 阳性上皮和基质细胞的数量减少。与对照组相比,用抗 L1 mAb 治疗的小鼠在植入部位的腹腔粘连数量也减少。此外,用抗神经丝 L 染色的神经的双盲计数显示,在抗 L1 处理的 B6C3F1 小鼠的腹膜病变中神经密度显著降低(P=0.0039)。
局部抗 L1 mAb 治疗抑制了 B6C3F1 和 CD-1 裸鼠的子宫内膜异位症生长,并对体内诱导的子宫内膜异位症病变产生了强大的抗神经生成作用。本研究在小鼠中的初步研究结果为进一步在体内模型中进行测试提供了坚实的基础。